The U.S. chondroitin sulfate market is expected to grow steadily over the next decade, expanding from USD 339.48 million in 2024 to USD 492.35 million by 2034, at a compound annual growth rate (CAGR) of 3.8%, according to recent industry analysis. The market's upward momentum is attributed to growing awareness of osteoarthritis, rising interest in preventive health...